Title:
RIP1 MODULATORS INCLUDING AZETIDINE CYCLIC UREAS, PREPARATIONS, AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/242581
Kind Code:
A1
Abstract:
Provided herein are compounds of Formula Ia and Ib, compositions comprising the same, and methods of using the same, including use in treating various diseases and conditions, including those mediated by receptor-interacting protein 1 (RIP1) signaling
Inventors:
ZHANG ZHAOLAN (CN)
ZHANG ZHIYUAN (CN)
SU YANING (CN)
XU YANPING (CN)
ZHANG ZHIYUAN (CN)
SU YANING (CN)
XU YANPING (CN)
Application Number:
PCT/CN2022/092907
Publication Date:
November 24, 2022
Filing Date:
May 16, 2022
Export Citation:
Assignee:
SIRONAX LTD (GB)
ZHANG ZHAOLAN (CN)
ZHANG ZHAOLAN (CN)
International Classes:
C07D231/06; A61K31/4155; A61P43/00; C07D205/04
Domestic Patent References:
| WO2020103884A1 | 2020-05-28 | |||
| WO2021233396A1 | 2021-11-25 | |||
| WO2003079973A2 | 2003-10-02 | |||
| WO2019224773A1 | 2019-11-28 |
Foreign References:
| CN107624111A | 2018-01-23 |
Attorney, Agent or Firm:
CHINA PATENT AGENT (H.K.) LTD. (CN)
Download PDF:
Previous Patent: NEW TYPE FLIP FRAME
Next Patent: INDENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS
Next Patent: INDENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS